Literature DB >> 1650942

High-performance liquid chromatographic determination of 2',3'-didehydro-3'-deoxythymidine (d4T) in human and rabbit plasma and urine and its application to pharmacokinetic studies in the rabbit.

S L Wong1, R J Sawchuk.   

Abstract

A rapid and sensitive liquid chromatographic assay for 2',3'-didehydro-3'-deoxythymidine (d4T) in plasma and urine is described. This assay uses thymidine oxetane (TO), a synthetic precursor of d4T, as internal standard. Sample preparation involves a simple extraction of plasma or urine with 5% isopropyl alcohol in methylene chloride. The method is specific and sensitive, allowing a linear response over a 2000-fold range of concentrations in human plasma (5 ng/ml to 10 micrograms/ml) and urine (50 ng/ml to 100 micrograms/ml). This assay, developed for human plasma and urine, is also applicable to rabbit samples with minor modification. Intravenous bolus doses of 10 mg/kg d4T to rabbits showed that the plasma concentration-time profile followed a biexponential decay. Estimates of the distribution and elimination half-lives were 6.7 +/- 0.9 and 51 +/- 6 min, respectively. The total-body and renal clearances were 23.4 +/- 3.6 and 8.82 +/- 3.9 ml/min.kg, respectively. That the renal clearance exceeds the glomerular filtration rate in the rabbit suggests that d4T is actively secreted in the renal tubule. The fraction excreted unchanged in the urine was 36 +/- 8%. Similar results were obtained in the same rabbits at steady state during constant-rate intravenous infusion. Noncompartmental analysis estimates of the MRT and Vdss were 46 +/- 5 min and 1.08 +/- 0.13 L/kg, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650942     DOI: 10.1023/a:1015808808115

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Analytical method for the quantification of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus (HIV) agent, by high-performance liquid chromatography (HPLC) and ultraviolet (UV) detection in rat and monkey plasma.

Authors:  S Kaul; K A Dandekar; K A Pittman
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

2.  Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.

Authors:  T S Lin; R F Schinazi; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858

3.  Microcomputer based pharmacokinetic programs for calculating absorption rate.

Authors:  K K Chan; K Wnuck
Journal:  Comput Programs Biomed       Date:  1983 Feb-Apr

4.  Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.

Authors:  Y Hamamoto; H Nakashima; T Matsui; A Matsuda; T Ueda; N Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  Nucleosides. IX. The formation of 2',2'-unsaturated pyrimidine nucleosides via a novel beta-elimination reaction.

Authors:  J R Horwitz; J Chua; M A Da Rooge; M Noel; I L Klundt
Journal:  J Org Chem       Date:  1966-01       Impact factor: 4.354

6.  Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.

Authors:  M A Hedaya; R J Sawchuk
Journal:  J Pharm Sci       Date:  1989-09       Impact factor: 3.534

7.  A sensitive and specific liquid-chromatographic assay for determination of ganciclovir in plasma and urine and its application to pharmacokinetic studies in the rabbit.

Authors:  M A Hedaya; R J Sawchuk
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

8.  3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.

Authors:  P Herdewijn; J Balzarini; E De Clercq; R Pauwels; M Baba; S Broder; H Vanderhaeghe
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

9.  Pharmacokinetics of propylene glycol in the rabbit.

Authors:  D K Yu; R J Sawchuk
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

10.  The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.

Authors:  J Balzarini; G J Kang; M Dalal; P Herdewijn; E De Clercq; S Broder; D G Johns
Journal:  Mol Pharmacol       Date:  1987-07       Impact factor: 4.436

  10 in total
  3 in total

1.  Radioimmunoassay for quantitation of 2',3'-didehydro-3'-deoxythymidine (D4T) in human plasma.

Authors:  X J Zhou; H Chakboub; B Ferrua; J Moravek; R Guedj; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat.

Authors:  Z Yang; R C Brundage; R H Barbhaiya; R J Sawchuk
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

3.  Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.

Authors:  S Kaul; K A Dandekar
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.